Cargando…
The Inflation Reduction Act: A boon for the generic and biosimilar industry
WHAT IS KNOWN AND OBJECTIVE: After more than a year of negotiation, a $740 billion climate and health care bill known as The Inflation Reduction Act (IRA) became law on 16 August 2022. In addition to its impact on the environment, job creation and reducing inflation, a key focus is to reduce the bur...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828046/ https://www.ncbi.nlm.nih.gov/pubmed/36207987 http://dx.doi.org/10.1111/jcpt.13783 |